Skip to content
Interested in access to new research? contact us
News & Press

Mymee Featured on Willis Towers Watson 'Cure for Common Co' Podcast

We were so excited to be asked to join the Cure for the Common Co podcast that has been created by the talented folks at Willis Towers Watson, a leading global advisory that helps it's clients manage risk, optimize benefits, cultivate talent, and expand the power of capital.

The Cure for the Common Co podcast is aimed at changing the way healthcare and employee benefits are delivered. In each episode, they interview entrepreneurs who have created innovative technologies in the healthcare and benefits space. Interviewees include the likes of  Sami Inkinen, MS, MBA (Virta),  Lindsay Jurist-Rosner (Wellthy) and Peter Shalek (AbleTo, Joyable). Mette tells the story of her personal journey that led her to found Mymee, a digital therapeutic that provides a platform for understanding the triggers that can set off the immune systems of those suffering from chronic illnesses. She explains how Mymee can be used to treat autoimmune diseases without medication. Listen Mette on Episode 3 as she dives into the challenges of the chronic autoimmune space for employers. 

 

For employers looking to elevate their benefits and wellness programs, this podcast is not to be missed. 

 

Health & Diet Tips

The Facts about Hydroxychloroquine (Plaquenil) Shortages

Science & Research

Environment is More Important than Genes for Immune System Function

News & Press

Mymee Launches COVID Long Haul Digital Care Program to Help Sufferers